Japan’s Astellas Pharma to Buy Audentes Therapeutics to Expand into Gene Therapy Market
It was reported by Reuters and several other media that the Japan-based Astellas Pharma has agreed to buy the US-based Audentes Therapeutics for...
405 Views
Astellas Pharma - Another Buyback
An hour ago, Astellas Pharma (4503 JP) announced a buyback for up to 32mm shares (around 1.7% of shares outstanding excluding Treasury shares) and...
360 Views
The BIG BUY of Z
18 months ago, Altaba Inc (AABA US) announced it would start selling down its 2bn shares-plus of Yahoo Japan - as of two days ago renamed Z...
751 Views
Japan: The 2018-Q3 Cash Flow Stakes - Runners, Riders & Red Flags
JAPAN CORPORATE CASH FLOW UPDATE - This insight updates our previous Insight Yen Weakens > Normal Service Resumed with data from all of the...
684 Views
Japan Pharma - Top Picks
While Gni Group Ltd (2160 JP) is our high risk-high return pick, Mitsubishi Tanabe Pharma (4508 JP) is a contrarian call in anticipation of value...
542 Views